Mediatorsof inflammation, such as cellular adhesion molecules, cytokines,leukotrienes, and NF-kB signaling factors, represent potentialtherapeutic targets in SCD [21]. The gene discussed is NFKB1; the disease is Schnyder corneal dystrophy.